Isolation of Bowman-Birk-Inhibitor from soybean extracts using novel peptide probes and high gradient magnetic separation

被引：27

作者：

Fields, Conor ^{[1
]}

Mallee, Paul ^{[1
]}

Muzard, Julien ^{[1
]}

Lee, Gil U. ^{[1
]}

机构：

[1] Natl Univ Ireland Univ Coll Dublin, Sch Chem & Chem Biol, Nanomed Ctr, Dublin 4, Ireland

来源：

FOOD CHEMISTRY | 2012年 / 134卷 / 04期

关键词：

Soybean proteins; Bowman-Birk Inhibitor; Phage display; Superparamagnetic particles; Purification; Soluble peptide binders; PROTEASE INHIBITOR; IN-VITRO; TRYPSIN; CHYMOTRYPSIN; RESOLUTION;

D O I：

10.1016/j.foodchem.2012.03.085

中图分类号：

O69 [应用化学];

学科分类号：

081704 ;

摘要：

Soybean proteins offer exceptional promise in the area of cancer prevention and treatment. Specifically, Bowman-Birk Inhibitor (BBI) has the ability to suppress carcinogenesis in vivo, which has been attributed to BBI's inhibition of serine protease (trypsin and chymotrypsin) activity. The lack of molecular probes for the isolation of this protein has made it difficult to work with, limiting its progress as a significant candidate in the treatment of cancer. This study has successfully identified a set of novel synthetic peptides targeting the BBI, and has demonstrated the ability to bind BBI in vitro. One of those probes has been covalently immobilised on superparamagnetic microbeads to allow the isolation of BBI from soy whey mixtures in a single step. Our ultimate goal is the use of the described synthetic probe to facilitate the isolation of this potentially therapeutic protein for low cost, scalable analysis and production of BBI (C) 2012 Elsevier Ltd. All rights reserved.

引用

页码：1831 / 1838

页数：8

共 29 条

[1]

[Anonymous], 1989, Molecular Cloning: A Laboratory

[2] In vitro inhibition of the activation of pro-matrix metalloproteinase 1 (Pro-MMP-1) and pro-matrix metalloproteinase 9 (Pro-MMP-9) by rice and soybean Bowman-Birk inhibitors [J].

Bawadi, HA ;

Antunes, TM ;

Shih, F ;

Losso, JN .

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2004, 52 (15) :4730-4736

[3] THE BOWMAN-BIRK INHIBITOR - TRYPSIN-INHIBITOR AND CHYMOTRYPSIN-INHIBITOR FROM SOYBEANS [J].

BIRK, Y .

INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH, 1985, 25 (02) :113-131

[4]

Birk Y., 1961, BIOCHIM BIOPHYS ACTA, V54, P191

[5]

Bode W., 1992, EUROPEAN J BIOCH, V204, P103

[6]

BOWMAN DE, 1946, P SOC EXP BIOL MED, V63, P547

[7] MONOCLONAL ANTIBODY-BASED ENZYME-IMMUNOASSAY OF THE BOWMAN-BIRK PROTEASE INHIBITOR OF SOYBEANS [J].

BRANDON, DL ;

BATES, AH ;

FRIEDMAN, M .

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1989, 37 (04) :1192-1196

[8] Lunasin and Bowman-Birk Protease Inhibitor Concentrations of Protein Extracts from Enzyme-Assisted Aqueous Extraction of Soybeans [J].

de Moura, Juliana Maria Leite Nobrega ;

Hernandez-Ledesma, Blanca ;

de Almeida, Neiva Maria ;

Hsieh, Chia-Chien ;

de Lumen, Ben O. ;

Johnson, Lawrence A. .

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2011, 59 (13) :6940-6946

[9]

Fournier DB, 1998, CANCER EPIDEM BIOMAR, V7, P1055

[10] The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis [J].

Gran, B. ;

Tabibzadeh, N. ;

Martin, A. ;

Ventura, E. S. ;

Ware, J. H. ;

Zhang, G-X ;

Parr, J. L. ;

Kenned, A. R. ;

Rostami, A. M. .

MULTIPLE SCLEROSIS, 2006, 12 (06) :688-697

← 1 2 3 →